상세정보

  • HOME
  • 상세정보

Pharmacotherapy for Liver Cirrhosis and Its Complications [electronic resource]

Qi, Xingshun

책이미지
도서 상세정보
서평쓰기
서지사항
자료유형단행본
개인저자Qi, Xingshun.,editor.
Yang, Yongping.,editor.
단체저자명SpringerLink (Online service).
서명/저자사항Pharmacotherapy for Liver Cirrhosis and Its Complications [electronic resource] / edited by Xingshun Qi, Yongping Yang.
판사항1st ed. 2022.
형태사항XII, 240 p. 20 illus., 16 illus. in color:online resource.
기본자료 저록Springer Nature eBook
기타형태 저록Printed edition:9789811926143Printed edition:9789811926167Printed edition:9789811926174
ISBN9789811926150
기타표준부호10.1007/978-981-19-2615-0
내용주기Anti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.
요약This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
일반주제명Internal medicine.
Internal Medicine.
바로가기URL